Skip to main content

In the form of a public service campaign designed to educate cancer patients and caregivers about managing the increased risk of infection during cancer treatment.

Chemotherapy is an important component of many cancer treatment plans, and while it often improves outcomes for patients, chemotherapy can be associated with unpleasant and sometimes life-threatening side effects. Neutropenia occurs when white blood cells (immune cells) are destroyed by chemotherapy.

Chemotherapy-induced neutropenia can become a serious condition for several reasons: many patients who develop neutropenia will require a delay in treatment or a dose reduction, which can prevent them from receiving full benefits of treatment; patients who develop neutropenia may require hospitalization; and even minor infections can become life-threatening.

Because cancer patients are often overwhelmed with medical information, many do not fully understand the risk of infection and its potential impact on treatment. With their new public service campaign, Stand Up to Cancer is encouraging cancer patients and caregivers to actively work with their physicians to learn how to reduce their risk of infection.

Scroll to Continue

Recommended Articles

Leukemia News Updates

Tibsovo Treatment of Acute Myeloid Leukemia

Tibsovo approved for treatment of newly diagnosed and relapsed Acute Myeloid Leukemia with an IGH1 mutation

Image placeholder title

Bispecific Antibody Precision Immunotherapy in non-Hodgkin lymphoma

Epcoritimab and other bi-specific antibody immunotherapies effective in refractory NHL - New option for elderly patients?

shutterstock_1226264584

Male BRCA2 Carriers Have Increased Lifetime Risk of Breast Cancer

Some men are at increased hereditary risk of developing breast cancer.

The public service campaign is called Manage Your Treatment and includes print and broadcast announcements, which will air this fall and appear in major lifestyle magazines. For more information, patients can visit www.manageyourtreatment.com.

Copyright © 2018 CancerConnect. All Rights Reserved.